Drug reference
rocuro-nium
Competitive antagonist of nicotinic ACh receptor
Competitive antagonist of nicotinic ACh receptor
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Rocuro-nium inhibits the nicotinic acetylcholine (ACh) receptor in the neuromuscular junction without effect on the ganglionic or CNS receptor, due to distinct subunit compositions.
Indications
muscle relaxation during surgery
Related guidelines
Ask House about rocuro-nium
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team